تجاوز إلى المحتوى الرئيسي
المنتج التاريخ معلومات السلامة المرفقات
Esbriet (pirfenidone) 2020-12-14

Esbriet (pirfenidone): Important safety update and new recommendations to prevent Drug-Induced Liver Injury (DILI)

Levon (Levofloxacin Hemihydrate) / Moxiflox (Moxifloxacin) 2020-11-19

Systemic and inhaled fluoroquinolones: warning about new risk of heart valve regurgitation/incompetence.

Tarivid (Ofloxacin) / Tavanic (Levofloxacin) 2020-11-05

Systemic and inhaled fluoroquinolones: warning about new risk of heart valve regurgitation/incompetence.

Revlimid® (Lenalidomide) 2020-10-21

Notification of typographical error in the Revlimid® (Lenalidomide) Hard Capsules Patient Information Leaflet (PIL)

Motilium (Domperidone) 2020-10-18

Removal of the paediatric posology and reminder of indication and contraindications related to serious cardiac side-effects

Levofloxacin Sandoz (Levofloxacin) 2020-09-13

Systemic fluoroquinolones: risk of heart valve regurgitation

Hydrochlorothiazide 2020-08-24

Hydrochlorothiazide - Association with non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)

Co-olmepress / Co-cinfaval 2020-08-19

Hydrochlorothiazide - Risk of non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)

Curacne (Isotretinoin) 2020-08-19

Isotretinoin - update on teratogenicity and neuropsychiatric disorders

5-Fluorouracil Capecitabine 2020-07-27

5-Fluorouracil (i.v.) and capecitabine containing products: Pre-treatment testing to identify DPD-deficient patients at increased risk of severe toxicity.

عرض 1 - 10 من 99